{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T11:12:59Z","timestamp":1720264379601},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1007\/s11883-000-0025-0","type":"journal-article","created":{"date-parts":[[2007,5,22]],"date-time":"2007-05-22T07:38:51Z","timestamp":1179819531000},"page":"232-242","source":"Crossref","is-referenced-by-count":28,"title":["Postprandial lipemia and coronary risk"],"prefix":"10.1007","volume":"2","author":[{"given":"Wolfgang","family":"Patsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Esterbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"F\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef R.","family":"Patsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"25_CR1","first-page":"413","volume":"2","author":"JW Gofman","year":"1954","unstructured":"Gofman JW, Delalla O, Glazier F, et al.: The serum lipid transport system in health, metabolic disorder, atherosclerosis, and coronary artery disease. Plasma 1954, 2: 413\u2013484.","journal-title":"Plasma"},{"key":"25_CR2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1001\/archinte.1959.00270010010002","volume":"103","author":"M Albrink","year":"1959","unstructured":"Albrink M, Man E: Serum triglycerides in coronary artery disease. Arch Intern Med 1959, 103: 4\u20138.","journal-title":"Arch Intern Med"},{"key":"25_CR3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/bmj.2.4993.640","volume":"2","author":"D Barritt","year":"1956","unstructured":"Barritt D: Alimentary lipaemia in men with coronary artery disease. Br Med J 1956, 2: 640\u2013644.","journal-title":"Br Med J"},{"key":"25_CR4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM196104132641501","volume":"264","author":"D Brown","year":"1961","unstructured":"Brown D, Heslin A, Doyle J: Postprandial lipemia in health and in ischemic heart disease. N Engl J Med 1961, 264: 733\u2013737.","journal-title":"N Engl J Med"},{"key":"25_CR5","first-page":"115","volume":"25","author":"M Denborough","year":"1963","unstructured":"Denborough M, Paterson B: Alimentary lipaemia in ischaemic heart disease. Clin Sci 1963, 25: 115\u2013122.","journal-title":"Clin Sci"},{"key":"25_CR6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0002-8703(63)90070-X","volume":"66","author":"W Harlan","year":"1963","unstructured":"Harlan W, Beischer D: Changes in serum lipoproteins after a large fat meal in normal individuals and in patients with ischemic heart disease. Am Heart J 1963, 66: 61\u201367.","journal-title":"Am Heart J"},{"key":"25_CR7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0140-6736(75)92376-4","volume":"1","author":"GJ Miller","year":"1975","unstructured":"Miller GJ, Miller NE: Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1975, 1: 16\u201319.","journal-title":"Lancet"},{"key":"25_CR8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.0954-6820.1979.tb13526.x","volume":"206","author":"LA Carlson","year":"1979","unstructured":"Carlson LA, Bottiger LE, Ahfeldt PE: Risk factors for myocardial infarction in the Stockholm prospective study: a 14-year follow-up focussing on the role of plasma triglycerides and cholesterol. Acta Med Scand 1979, 206: 351\u2013360.","journal-title":"Acta Med Scand"},{"key":"25_CR9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0021-9681(80)90022-3","volume":"33","author":"S Heyden","year":"1980","unstructured":"Heyden S, Heiss G, Hames CG, et al.: Fasting triglycerides as predictors of total and CHD mortality in Evans County, Georgia. J Chronic Dis 1980, 33: 275\u2013282.","journal-title":"J Chronic Dis"},{"key":"25_CR10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/BF00265546","volume":"32","author":"A Fontbonne","year":"1989","unstructured":"Fontbonne A, Eschwege E, Cambien F, et al.: Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 1989, 32: 300\u2013304.","journal-title":"Diabetologia"},{"key":"25_CR11","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM198006193022503","volume":"302","author":"SB Hulley","year":"1980","unstructured":"Hulley SB, Rosenman RH, Bawol RD, et al.: Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart disease. N Engl J Med 1980, 302: 1383\u20131389.","journal-title":"N Engl J Med"},{"key":"25_CR12","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJM199304293281702","volume":"328","author":"MH Criqui","year":"1993","unstructured":"Criqui MH, Heiss G, Cohn R, et al.: Plasma triglyceride level and mortality from coronary heart disease [see comments]. N Engl J Med 1993, 328: 1220\u20131225.","journal-title":"N Engl J Med"},{"key":"25_CR13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0022-2275(20)34958-0","volume":"22","author":"SR Behr","year":"1981","unstructured":"Behr SR, Patsch JR, Forte T, et al.: Plasma lipoprotein changes resulting from immunologically blocked lipolysis. J Lipid Res 1981, 22: 443\u2013451.","journal-title":"J Lipid Res"},{"key":"25_CR14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1126\/science.2167514","volume":"249","author":"Y Ito","year":"1990","unstructured":"Ito Y, Azrolan N, O\u2019Connell A, et al.: Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 1990, 249: 790\u2013793.","journal-title":"Science"},{"key":"25_CR15","first-page":"1913","volume-title":"The metabolic basis of inherited disease","author":"JD Brunzell","year":"1995","unstructured":"Brunzell JD: Familial lipoprotein lipasse deficiency and other causes of the chylomicronemia syndrome. In The metabolic basis of inherited disease, 7 edn. In Edited by Scriver C, Beaudet A, Sly W, Valle D. New York: McGraw-Hill; 1995:1913\u20131932.","edition":"7 edn."},{"key":"25_CR16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/clinchem\/36.2.207","volume":"36","author":"SA Brown","year":"1990","unstructured":"Brown SA, Boerwinkle E, Kashanian FK, et al.: Variation in concentration of lipids, lipoprotein lipids, and apolipoproteins A-I and B in plasma from healthy women. Clin Chem 1990, 36: 207\u2013210.","journal-title":"Clin Chem"},{"issue":"Suppl M","key":"25_CR17","first-page":"M8","volume":"19","author":"G Assmann","year":"1998","unstructured":"Assmann G, Schulte H, Funke H, et al.: The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur Heart J 1998, 19 Suppl M: M8\u201314.","journal-title":"Eur Heart J"},{"key":"25_CR18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0002-9149(96)00159-2","volume":"77","author":"G Assmann","year":"1996","unstructured":"Assmann G, Schulte H, von Eckardstein A: Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996, 77: 1179\u20131184.","journal-title":"Am J Cardiol"},{"key":"25_CR19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI108513","volume":"58","author":"RL Hamilton","year":"1976","unstructured":"Hamilton RL, Williams MC, Fielding CJ, et al.: Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver. J Clin Invest 1976, 58: 667\u2013680.","journal-title":"J Clin Invest"},{"key":"25_CR20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1172\/JCI108963","volume":"61","author":"PH Green","year":"1978","unstructured":"Green PH, Tall AR, Glickman RM. Rat intestine secretes discoid high density lipoprotein. J Clin Invest 1978, 61: 528\u2013534.","journal-title":"J Clin Invest"},{"key":"25_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-024911-4.50008-8","volume":"11","author":"JA Glomset","year":"1973","unstructured":"Glomset JA: The metabolic role of lecithin: cholesterol acyltransferase: perspectives from pathology. Adv Lipid Res 1973, 11: 1\u201365.","journal-title":"Adv Lipid Res"},{"key":"25_CR22","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1016\/S0021-9258(18)34757-4","volume":"257","author":"CE Matz","year":"1982","unstructured":"Matz CE, Jonas A: Reaction of human lecithin cholesterol acyltransferase with synthetic micellar complexes of apolipoprotein A-I, phosphatidylcholine, and cholesterol. J Biol Chem 1982, 257: 4541\u20134546.","journal-title":"J Biol Chem"},{"key":"25_CR23","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJM197811302992207","volume":"299","author":"AR Tall","year":"1978","unstructured":"Tall AR, Small DM: Plasma high-density lipoproteins. N Engl J Med 1978, 299: 1232\u20131236.","journal-title":"N Engl J Med"},{"key":"25_CR24","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1073\/pnas.75.9.4519","volume":"75","author":"JR Patsch","year":"1978","unstructured":"Patsch JR, Gotto AMJ, Olivercrona T, et al.: Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci U S A 1978, 75: 4519\u20134523.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"25_CR25","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/S0021-9258(19)69912-6","volume":"256","author":"AR Tall","year":"1981","unstructured":"Tall AR, Green PH: Incorporation of phosphatidylcholine into spherical and discoidal lipoproteins during incubation of egg phosphatidylcholine vesicles with isolated high density lipoproteins or with plasma. J Biol Chem 1981, 256: 2035\u20132044.","journal-title":"J Biol Chem"},{"key":"25_CR26","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI114024","volume":"83","author":"BH Chung","year":"1989","unstructured":"Chung BH, Segrest JP, Smith K, et al.: Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. A possible mechanism of atherogenesis? J Clin Invest 1989, 83: 1363\u20131374.","journal-title":"J Clin Invest"},{"key":"25_CR27","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1172\/JCI111624","volume":"74","author":"JR Patsch","year":"1984","unstructured":"Patsch JR, Prasad S, Gotto AMJ, et al.: Postprandial lipemia: a key for the conversion of high density lipoprotein 2 into high-density lipoprotein 3 by hepatic lipase. J Clin Invest 1984, 74: 2017\u20132023.","journal-title":"J Clin Invest"},{"key":"25_CR28","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0022-2275(20)36957-1","volume":"34","author":"AR Tall","year":"1993","unstructured":"Tall AR: Plasma cholesteryl ester transfer protein. J Lipid Res 1993, 34: 1255\u20131274.","journal-title":"J Lipid Res"},{"key":"25_CR29","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1172\/JCI115535","volume":"88","author":"CJ Mann","year":"1991","unstructured":"Mann CJ, Yen FT, Grant AM, et al.: Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991, 88: 2059\u20132066.","journal-title":"J Clin Invest"},{"key":"25_CR30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1172\/JCI104980","volume":"43","author":"PJ Nestel","year":"1964","unstructured":"Nestel PJ: Relationship between plasma triglycerides and removal of chylomicrons. J Clin Invest 1964, 43: 943\u2013949.","journal-title":"J Clin Invest"},{"key":"25_CR31","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI108999","volume":"61","author":"MF Reardon","year":"1978","unstructured":"Reardon MF, Fidge NH, Nestel PJ: Catabolism of very low density lipoprotein B apoprotein in man. J Clin Invest 1978, 61: 850\u2013860.","journal-title":"J Clin Invest"},{"key":"25_CR32","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0022-2275(20)38087-1","volume":"23","author":"EJ Schaefer","year":"1982","unstructured":"Schaefer EJ, Zech LA, Jenkins LL, et al.: Human apolipoprotein A-I and A-II metabolism. J Lipid Res 1982, 23: 850\u2013862.","journal-title":"J Lipid Res"},{"key":"25_CR33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00041433-199008000-00003","volume":"1","author":"M Lechleitner","year":"1990","unstructured":"Lechleitner M, Miesenbock G, Patsch JR: HDL cholesterol, triglycerides and coronary heart disease. Curr Opin Lipidol 1990, 1: 330\u2013333.","journal-title":"Curr Opin Lipidol"},{"key":"25_CR34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF01221966","volume":"12","author":"M Ahmed","year":"1976","unstructured":"Ahmed M, Gannon MC, Nuttall FQ: Postprandial plasma glucose, insulin, glucagon and triglyceride responses to a standard diet in normal subjects. Diabetologia 1976, 12: 61\u201367.","journal-title":"Diabetologia"},{"key":"25_CR35","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1073\/pnas.80.5.1449","volume":"80","author":"JR Patsch","year":"1983","unstructured":"Patsch JR, Karlin JB, Scott LW, et al.: Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci U S A 1983, 80: 1449\u20131453.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"25_CR36","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/oxfordjournals.aje.a116531","volume":"136","author":"SA Brown","year":"1992","unstructured":"Brown SA, Chambless LE, Sharrett AR, et al.: Postprandial lipemia: reliability in an epidemiologic field study. Am J Epidemiol 1992, 136: 538\u2013545.","journal-title":"Am J Epidemiol"},{"key":"25_CR37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI113078","volume":"80","author":"JR Patsch","year":"1987","unstructured":"Patsch JR, Prasad S, Gotto AMJ, et al.: High-density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987, 80: 341\u2013347.","journal-title":"J Clin Invest"},{"key":"25_CR38","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1161\/01.ATV.12.11.1336","volume":"12","author":"JR Patsch","year":"1992","unstructured":"Patsch JR, Miesenbock G, Hopferwieser T, et al.: Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb 1992, 12: 1336\u20131345.","journal-title":"Arterioscler Thromb"},{"key":"25_CR39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0021-9150(87)90020-7","volume":"65","author":"LA Simons","year":"1987","unstructured":"Simons LA, Dwyer T, Simons J, et al.: Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Atherosclerosis 1987, 65: 181\u2013189.","journal-title":"Atherosclerosis"},{"key":"25_CR40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0021-9150(90)90111-U","volume":"85","author":"HS Simpson","year":"1990","unstructured":"Simpson HS, Williamson CM, Olivecrona T, et al.: Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis 1990, 85: 193\u2013202.","journal-title":"Atherosclerosis"},{"key":"25_CR41","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/01.ATV.11.3.653","volume":"11","author":"PH Groot","year":"1991","unstructured":"Groot PH, van Stiphout WA, Krauss XH, et al.: Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991, 11: 653\u2013662.","journal-title":"Arterioscler Thromb"},{"key":"25_CR42","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1172\/JCI105468","volume":"45","author":"DS Goodman","year":"1966","unstructured":"Goodman DS, Blomstrand R, Werner B, et al.: The intestinal absorption and metabolism of vitamin A and beta-carotene in man. J Clin Invest 1966, 45: 1615\u20131623.","journal-title":"J Clin Invest"},{"key":"25_CR43","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1161\/01.ATV.15.12.2122","volume":"15","author":"AR Sharrett","year":"1995","unstructured":"Sharrett AR, Chambless LE, Heiss G, et al.: Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 1995, 15: 2122\u20132129.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25_CR44","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/01.ATV.15.11.1829","volume":"15","author":"HN Ginsberg","year":"1995","unstructured":"Ginsberg HN, Jones J, Blaner WS, et al.: Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler Thromb Vasc Biol 1995, 15: 1829\u20131838.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25_CR45","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/01.STR.23.6.823","volume":"23","author":"JE Ryu","year":"1992","unstructured":"Ryu JE, Howard G, Craven TE, et al.: Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects. Stroke 1992, 23: 823\u2013828.","journal-title":"Stroke"},{"key":"25_CR46","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/01.CIR.100.7.723","volume":"100","author":"S Boquist","year":"1999","unstructured":"Boquist S, Ruotolo G, Tang R, et al.: Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation 1999, 100: 723\u2013728.","journal-title":"Circulation"},{"key":"25_CR47","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.CIR.34.4.679","volume":"34","author":"JW Gofman","year":"1966","unstructured":"Gofman JW, Young W, Tandy R: Ischemic heart disease, atherosclerosis, and longevity. Circulation 1966, 34: 679\u2013697.","journal-title":"Circulation"},{"key":"25_CR48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","volume":"79","author":"DJ Gordon","year":"1989","unstructured":"Gordon DJ, Probstfield JL, Garrison RJ, et al.: High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989, 79: 8\u201315.","journal-title":"Circulation"},{"key":"25_CR49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/353265a0","volume":"353","author":"EM Rubin","year":"1991","unstructured":"Rubin EM, Krauss RM, Spangler EA, et al.: Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 1991, 353: 265\u2013267.","journal-title":"Nature"},{"key":"25_CR50","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.1073\/pnas.91.20.9607","volume":"91","author":"AS Plump","year":"1994","unstructured":"Plump AS, Scott CJ, Breslow JL: Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A 1994, 91: 9607\u20139611.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"25_CR51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/01.CIR.94.4.713","volume":"94","author":"N Duverger","year":"1996","unstructured":"Duverger N, Kruth H, Emmanuel F, et al.: Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits. Circulation 1996, 94: 713\u2013717.","journal-title":"Circulation"},{"key":"25_CR52","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1172\/JCI114558","volume":"85","author":"JJ Badimon","year":"1990","unstructured":"Badimon JJ, Badimon L, Fuster V: Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest 1990, 85: 1234\u20131241.","journal-title":"J Clin Invest"},{"key":"25_CR53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0005-2760(76)90155-7","volume":"431","author":"O Stein","year":"1976","unstructured":"Stein O, Vanderhoek J, Stein Y: Cholesterol content and sterol synthesis in human skin fibroblasts and rat aortic smooth muscle cells exposed to lipoprotein-depleted serum and high-density apolipoprotein\/phospholipid mixtures. Biochim Biophys Acta 1976, 431: 347\u2013358.","journal-title":"Biochim Biophys Acta"},{"key":"25_CR54","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.271.5248.518","volume":"271","author":"S Acton","year":"1996","unstructured":"Acton S, Rigotti A, Landschulz KT, et al.: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor [see comments]. Science 1996, 271: 518\u2013520.","journal-title":"Science"},{"key":"25_CR55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-2275(20)33357-5","volume":"40","author":"NH Fidge","year":"1999","unstructured":"Fidge NH: High density lipoprotein receptors, binding proteins, and ligands. J Lipid Res 1999, 40: 187\u2013201.","journal-title":"J Lipid Res"},{"key":"25_CR56","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0300-9629(82)90398-X","volume":"71","author":"YC Ha","year":"1982","unstructured":"Ha YC, Barter PJ: Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species. Comp Biochem Physiol [B] 1982, 71: 265\u2013269.","journal-title":"Comp Biochem Physiol [B]"},{"key":"25_CR57","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1172\/JCI109907","volume":"66","author":"JP Tauber","year":"1980","unstructured":"Tauber JP, Cheng J, Gospodarowicz D: Effect of high-and low-density lipoproteins on proliferation of cultured bovine vascular endothelial cells. J Clin Invest 1980, 66: 696\u2013708.","journal-title":"J Clin Invest"},{"key":"25_CR58","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0005-2760(90)90314-N","volume":"1044","author":"S Parthasarathy","year":"1990","unstructured":"Parthasarathy S, Barnett J, Fong LG: High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1990, 1044: 275\u2013283.","journal-title":"Biochim Biophys Acta"},{"key":"25_CR59","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1172\/JCI113682","volume":"82","author":"Y Yui","year":"1988","unstructured":"Yui Y, Aoyama T, Morishita H, et al.: Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I): a novel function of Apo A-I. J Clin Invest 1988, 82: 803\u2013807.","journal-title":"J Clin Invest"},{"key":"25_CR60","first-page":"1195","volume-title":"The Metabolic Basis of Inherited Disease","author":"R Mahley","year":"1989","unstructured":"Mahley R, Rall S: Type-III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In The Metabolic Basis of Inherited Disease, 6 edn. Edited by Scriver C, Beaudet A, Sly W, Valle D. New York: McGraw-Hill, 1989:1195\u20131214.","edition":"6 edn."},{"key":"25_CR61","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0022-2275(20)33414-3","volume":"40","author":"H Yagyu","year":"1999","unstructured":"Yagyu H, Ishibashi S, Chen Z, et al.: Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice. J Lipid Res 1999, 40: 1677\u20131685.","journal-title":"J Lipid Res"},{"key":"25_CR62","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1172\/JCI117460","volume":"94","author":"SH Zhang","year":"1994","unstructured":"Zhang SH, Reddick RL, Burkey B, et al.: Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest 1994, 94: 937\u2013945.","journal-title":"J Clin Invest"},{"key":"25_CR63","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1172\/JCI107334","volume":"52","author":"JD Brunzell","year":"1973","unstructured":"Brunzell JD, Hazzard WR, Porte DJ, et al.: Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest 1973, 52: 1578\u20131585.","journal-title":"J Clin Invest"},{"key":"25_CR64","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1172\/JCI106422","volume":"49","author":"RJ Havel","year":"1970","unstructured":"Havel RJ, Kane JP, Balasse EO, et al.: Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J Clin Invest 1970, 49: 2017\u20132035.","journal-title":"J Clin Invest"},{"key":"25_CR65","doi-asserted-by":"crossref","first-page":"13880","DOI":"10.1016\/S0021-9258(18)68326-7","volume":"263","author":"WY Craig","year":"1988","unstructured":"Craig WY, Nutik R, Cooper AD: Regulation of apoprotein synthesis and secretion in the human hepatoma Hep G2: the effect of exogenous lipoprotein. J Biol Chem 1988, 263: 13880\u201313890.","journal-title":"J Biol Chem"},{"key":"25_CR66","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1073\/pnas.90.5.2069","volume":"90","author":"BO Schneeman","year":"1993","unstructured":"Schneeman BO, Kotite L, Todd KM, et al.: Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci U S A 1993, 90: 2069\u20132073.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"25_CR67","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/S0022-2275(20)35345-1","volume":"34","author":"JS Cohn","year":"1993","unstructured":"Cohn JS, Johnson EJ, Millar JS, et al.: Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res 1993, 34: 2033\u20132040.","journal-title":"J Lipid Res"},{"key":"25_CR68","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1172\/JCI116293","volume":"91","author":"F Karpe","year":"1993","unstructured":"Karpe F, Steiner G, Olivecrona T, et al.: Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest 1993, 91: 748\u2013758.","journal-title":"J Clin Invest"},{"key":"25_CR69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.ATV.17.1.149","volume":"17","author":"U Olsson","year":"1997","unstructured":"Olsson U, Camejo G, Hurt-Camejo E, et al.: Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the ApoB\/E receptor. Arterioscler Thromb Vasc Biol 1997, 17: 149\u2013155.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25_CR70","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/01.ATV.8.4.368","volume":"8","author":"G Camejo","year":"1988","unstructured":"Camejo G, Olofsson SO, Lopez F, et al.: Identification of Apo B-100 segments mediating the interaction of low-density lipoproteins with arterial proteoglycans. Arteriosclerosis 1988, 8: 368\u2013377.","journal-title":"Arteriosclerosis"},{"key":"25_CR71","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1172\/JCI2265","volume":"101","author":"J Boren","year":"1998","unstructured":"Boren J, Olin K, Lee I, et al.: Identification of the principal proteoglycan-binding site in LDL: a single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding. J Clin Invest 1998, 101: 2658\u20132664.","journal-title":"J Clin Invest"},{"key":"25_CR72","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0021-9150(96)05842-X","volume":"124","author":"V Anber","year":"1996","unstructured":"Anber V, Griffin BA, McConnell M, et al.: Influence of plasma lipid and LDL-subfraction profile on the interaction between low-density lipoprotein with human arterial wall proteoglycans. Atherosclerosis 1996, 124: 261\u2013271.","journal-title":"Atherosclerosis"},{"key":"25_CR73","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.ATV.4.3.225","volume":"4","author":"RJ Deckelbaum","year":"1984","unstructured":"Deckelbaum RJ, Granot E, Oschry Y, et al.: Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis 1984, 4: 225\u2013231.","journal-title":"Arteriosclerosis"},{"key":"25_CR74","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1172\/JCI116411","volume":"91","author":"BJ McKeone","year":"1993","unstructured":"McKeone BJ, Patsch JR, Pownall HJ: Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells. J Clin Invest 1993, 91: 1926\u20131933.","journal-title":"J Clin Invest"},{"key":"25_CR75","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/01.ATV.13.5.712","volume":"13","author":"J Graaf de","year":"1993","unstructured":"de Graaf J, Hendriks JC, Demacker PN, et al.: Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects: normalization after clofibrate treatment. Arterioscler Thromb 1993, 13: 712\u2013719.","journal-title":"Arterioscler Thromb"},{"key":"25_CR76","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0021-9150(98)00037-9","volume":"138","author":"N Sattar","year":"1998","unstructured":"Sattar N, Petrie JR, Jaap AJ: The atherogenic lipoprotein phenotype and vascular endothelial dysfunction. Atherosclerosis 1998, 138: 229\u2013235.","journal-title":"Atherosclerosis"},{"key":"25_CR77","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1161\/01.ATV.14.11.1799","volume":"14","author":"M Lechleitner","year":"1994","unstructured":"Lechleitner M, Hoppichler F, Foger B, et al.: Low-density lipoproteins of the postprandial state induce cellular cholesteryl ester accumulation in macrophages. Arterioscler Thromb 1994, 14: 1799\u20131807.","journal-title":"Arterioscler Thromb"},{"key":"25_CR78","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.CIR.82.2.495","volume":"82","author":"MA Austin","year":"1990","unstructured":"Austin MA, King MC, Vranizan KM, et al.: Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk [see comments]. Circulation 1990, 82: 495\u2013506.","journal-title":"Circulation"},{"key":"25_CR79","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1172\/JCI116222","volume":"91","author":"G Miesenbock","year":"1993","unstructured":"Miesenbock G, Holzl B, Foger B, et al.: Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest 1993, 91: 448\u2013455.","journal-title":"J Clin Invest"},{"key":"25_CR80","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1172\/JCI119511","volume":"100","author":"MM Veniant","year":"1997","unstructured":"Veniant MM, Pierotti V, Newland D, et al.: Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. J Clin Invest 1997, 100: 180\u2013188.","journal-title":"J Clin Invest"},{"key":"25_CR81","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1001\/jama.1997.03550200058032","volume":"278","author":"GD Plotnick","year":"1997","unstructured":"Plotnick GD, Corretti MC, Vogel RA: Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal [see comments]. JAMA 1997, 278: 1682\u20131686.","journal-title":"JAMA"},{"key":"25_CR82","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00041433-199910000-00002","volume":"10","author":"M Evans","year":"1999","unstructured":"Evans M, Khan N, Rees A: Diabetic dyslipidaemia and coronary heart disease: new perspectives. Curr Opin Lipidol 1999, 10: 387\u2013391.","journal-title":"Curr Opin Lipidol"},{"key":"25_CR83","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00041433-199906000-00007","volume":"10","author":"JC Fruchart","year":"1999","unstructured":"Fruchart JC, Duriez P, Staels B: Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr Opin Lipidol 1999, 10: 245\u2013257.","journal-title":"Curr Opin Lipidol"},{"key":"25_CR84","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(83)91849-4","volume":"1","author":"HC Simpson","year":"1983","unstructured":"Simpson HC, Mann JI, Meade TW, et al.: Hypertriglyceridaemia and hypercoagulability. Lancet 1983, 1: 786\u2013790.","journal-title":"Lancet"},{"key":"25_CR85","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0021-9150(91)90212-L","volume":"86","author":"GJ Miller","year":"1991","unstructured":"Miller GJ, Martin JC, Mitropoulos KA, et al.: Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition. Atherosclerosis 1991, 86: 163\u2013171.","journal-title":"Atherosclerosis"},{"key":"25_CR86","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0021-9150(97)00260-8","volume":"137","author":"A Broijersen","year":"1998","unstructured":"Broijersen A, Karpe F, Hamsten A, et al.: Alimentary lipemia enhances the membrane expression of platelet P-selectin without affecting other markers of platelet activation. Atherosclerosis 1998, 137: 107\u2013113.","journal-title":"Atherosclerosis"},{"key":"25_CR87","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198512193132501","volume":"313","author":"A Hamsten","year":"1985","unstructured":"Hamsten A, Wiman B, de Faire U, et al.: Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985, 313: 1557\u20131563.","journal-title":"N Engl J Med"},{"key":"25_CR88","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/01.ATV.10.6.1067","volume":"10","author":"A Stiko-Rahm","year":"1990","unstructured":"Stiko-Rahm A, Wiman B, Hamsten A, et al.: Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low-density lipoprotein. Arteriosclerosis 1990, 10: 1067\u20131073.","journal-title":"Arteriosclerosis"},{"key":"25_CR89","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.ATV.14.7.1098","volume":"14","author":"AR Sharrett","year":"1994","unstructured":"Sharrett AR, Patsch W, Sorlie PD, et al.: Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1994, 14: 1098\u20131104.","journal-title":"Arterioscler Thromb"},{"key":"25_CR90","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJM199011013231803","volume":"323","author":"A Inazu","year":"1990","unstructured":"Inazu A, Brown ML, Hesler CB, et al.: Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 1990, 323: 1234\u20131238.","journal-title":"N Engl J Med"},{"key":"25_CR91","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1161\/01.ATV.17.12.3433","volume":"17","author":"A Ritsch","year":"1997","unstructured":"Ritsch A, Drexel H, Amann FW, et al.: Deficiency of cholesteryl ester transfer protein: description of the molecular defect and the dissociation of cholesteryl ester and triglyceride transport in plasma. Arterioscler Thromb Vasc Biol 1997, 17: 3433\u20133441.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25_CR92","doi-asserted-by":"crossref","first-page":"27393","DOI":"10.1074\/jbc.272.43.27393","volume":"272","author":"B Foger","year":"1997","unstructured":"Foger B, Santamarina-Fojo S, Shamburek RD, et al.: Plasma phospholipid transfer protein: adenovirus-mediated overexpression in mice leads to decreased plasma high-density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. J Biol Chem 1997, 272: 27393\u201327400.","journal-title":"J Biol Chem"},{"key":"25_CR93","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/01.ATV.9.2.217","volume":"9","author":"JR Merrill","year":"1989","unstructured":"Merrill JR, Holly RG, Anderson RL, et al.: Hyperlipemic response of young trained and untrained men after a high fat meal. Arteriosclerosis 1989, 9: 217\u2013223.","journal-title":"Arteriosclerosis"},{"key":"25_CR94","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1079\/PNS19970068","volume":"56","author":"CM Williams","year":"1997","unstructured":"Williams CM: Postprandial lipid metabolism: effects of dietary fatty acids. Proc Nutr Soc 1997, 56: 679\u2013692.","journal-title":"Proc Nutr Soc"},{"key":"25_CR95","doi-asserted-by":"crossref","first-page":"967","DOI":"10.7326\/0003-4819-114-11-967","volume":"114","author":"D Steinberg","year":"1991","unstructured":"Steinberg D, Pearson TA, Kuller LH: Alcohol and atherosclerosis. Ann Intern Med 1991, 114: 967\u2013976.","journal-title":"Ann Intern Med"},{"key":"25_CR96","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1161\/01.ATV.17.10.2096","volume":"17","author":"N Mero","year":"1997","unstructured":"Mero N, Syvanne M, Eliasson B, et al.: Postprandial elevation of ApoB-48-containing triglyceride-rich particles and retinyl esters in normolipemic males who smoke. Arterioscler Thromb Vasc Biol 1997, 17: 2096\u20132102.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25_CR97","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0022-2275(20)38520-5","volume":"29","author":"JS Cohn","year":"1988","unstructured":"Cohn JS, McNamara JR, Cohn SD, et al.: Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 1988, 29: 469\u2013479.","journal-title":"J Lipid Res"},{"key":"25_CR98","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1161\/01.ATV.19.10.2448","volume":"19","author":"C Couillard","year":"1999","unstructured":"Couillard C, Bergeron N, Prud\u2019homme D, et al.: Gender difference in postprandial lipemia: importance of visceral adipose tissue accumulation. Arterioscler Thromb Vasc Biol 1999, 19: 2448\u20132455.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25_CR99","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1161\/01.ATV.19.11.2737","volume":"19","author":"AP Beek van","year":"1999","unstructured":"van Beek AP, de Ruijter-Heijstek FC, Erkelens DW, et al.: Menopause is associated with reduced protection from postprandial lipemia. Arterioscler Thromb Vasc Biol 1999, 19: 2737\u20132741.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25_CR100","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0026-0495(99)90137-3","volume":"48","author":"M Weintraub","year":"1999","unstructured":"Weintraub M, Grosskopf I, Charach G, et al.: Hormone replacement therapy enhances postprandial lipid metabolism in postmenopausal women. Metabolism 1999, 48: 1193\u20131196.","journal-title":"Metabolism"},{"key":"25_CR101","first-page":"838","volume":"43","author":"MA Austin","year":"1988","unstructured":"Austin MA, King MC, Vranizan KM, et al.: Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet 1988, 43: 838\u2013846.","journal-title":"Am J Hum Genet"},{"key":"25_CR102","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1073\/pnas.89.2.708","volume":"89","author":"PM Nishina","year":"1992","unstructured":"Nishina PM, Johnson JP, Naggert JK, et al.: Linkage of atherogenic lipoprotein phenotype to the low-density lipoprotein receptor locus on the short arm of chromosome 19. Proc Natl Acad Sci U S A 1992, 89: 708\u2013712.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"25_CR103","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0021-9150(94)90129-5","volume":"106","author":"BA Griffin","year":"1994","unstructured":"Griffin BA, Freeman DJ, Tait GW, et al.: Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994, 106: 241\u2013253.","journal-title":"Atherosclerosis"},{"key":"25_CR104","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1161\/01.ATV.15.11.1839","volume":"15","author":"CE Tan","year":"1995","unstructured":"Tan CE, Foster L, Caslake MJ, et al.: Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and women. Arterioscler Thromb Vasc Biol 1995, 15: 1839\u20131848.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25_CR105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/907","volume":"19","author":"DA Nickerson","year":"1998","unstructured":"Nickerson DA, Taylor SL, Weiss KM, et al.: DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene [see comments]. Nat Genet 1998, 19: 233\u2013240.","journal-title":"Nat Genet"},{"key":"25_CR106","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ng0595-28","volume":"10","author":"PW Reymer","year":"1995","unstructured":"Reymer PW, Gagne E, Groenemeyer BE, et al.: A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis [see comments]. Nat Genet 1995, 10: 28\u201334.","journal-title":"Nat Genet"},{"key":"25_CR107","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0022-2275(20)37571-4","volume":"37","author":"M Syvanne","year":"1996","unstructured":"Syvanne M, Antikainen M, Ehnholm S, et al.: Heterozygosity for Asn291Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia. J Lipid Res 1996, 37: 727\u2013738.","journal-title":"J Lipid Res"},{"key":"25_CR108","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0022-2275(20)33412-X","volume":"40","author":"N Mero","year":"1999","unstructured":"Mero N, Suurinkeroinen L, Syvanne M, et al.: Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant. J Lipid Res 1999, 40: 1663\u20131670.","journal-title":"J Lipid Res"},{"key":"25_CR109","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.CIR.96.3.733","volume":"96","author":"C Gerdes","year":"1997","unstructured":"Gerdes C, Fisher RM, Nicaud V, et al.: Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies. Circulation 1997, 96: 733\u2013740.","journal-title":"Circulation"},{"issue":"25 Suppl","key":"25_CR110","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/00005344-199506001-00007","volume":"4","author":"DJ Galton","year":"1995","unstructured":"Galton DJ: Common genetic determinants of dyslipidemia: the hypertriglyceridemia\/low-high-density lipoprotein syndrome. J Cardiovasc Pharmacol 1995, 25 Suppl 4: S35-S40.","journal-title":"J Cardiovasc Pharmacol"},{"key":"25_CR111","first-page":"270","volume":"19","author":"R Jemaa","year":"1995","unstructured":"Jemaa R, Tuzet S, Portos C, et al.: Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int J Obes Relat Metab Disord 1995, 19: 270\u2013274.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"25_CR112","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/01.CIR.95.12.2628","volume":"95","author":"BE Groenemeijer","year":"1997","unstructured":"Groenemeijer BE, Hallman MD, Reymer PW, et al.: Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients: the Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group [see comments]. Circulation 1997, 95: 2628\u20132635.","journal-title":"Circulation"},{"key":"25_CR113","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0005-2760(96)00059-8","volume":"1302","author":"H Zhang","year":"1996","unstructured":"Zhang H, Henderson H, Gagne SE, et al.: Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta 1996, 1302: 159\u2013166.","journal-title":"Biochim Biophys Acta"},{"key":"25_CR114","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.ATV.18.4.526","volume":"18","author":"SE Humphries","year":"1998","unstructured":"Humphries SE, Nicaud V, Margalef J, et al.: Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc Biol 1998, 18: 526\u2013534.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25_CR115","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0022-2275(20)32543-8","volume":"39","author":"PJ Talmud","year":"1998","unstructured":"Talmud PJ, Hall S, Holleran S, et al.: LPL promoter -93T\/G transition influences fasting and postprandial plasma triglycerides response in African-Americans and Hispanics. J Lipid Res 1998, 39: 1189\u20131196.","journal-title":"J Lipid Res"},{"key":"25_CR116","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI113243","volume":"80","author":"MS Weintraub","year":"1987","unstructured":"Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987, 80: 1571\u20131577.","journal-title":"J Clin Invest"},{"key":"25_CR117","first-page":"341","volume":"54","author":"E Boerwinkle","year":"1994","unstructured":"Boerwinkle E, Brown S, Sharrett AR, et al.: Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am J Hum Genet 1994, 54: 341\u2013360.","journal-title":"Am J Hum Genet"},{"key":"25_CR118","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0021-9150(99)00069-6","volume":"145","author":"J Dallongeville","year":"1999","unstructured":"Dallongeville J, Tiret L, Visvikis S, et al.: Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: the EARS II study: European Atherosclerosis Research Study. Atherosclerosis 1999, 145: 381\u2013388.","journal-title":"Atherosclerosis"},{"key":"25_CR119","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1172\/JCI118408","volume":"97","author":"N Bergeron","year":"1996","unstructured":"Bergeron N, Havel RJ. Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele. J Clin Invest 1996, 97: 65\u201372.","journal-title":"J Clin Invest"},{"key":"25_CR120","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1161\/01.ATV.11.6.1737","volume":"11","author":"AJ Brown","year":"1991","unstructured":"Brown AJ, Roberts DC: The effect of fasting triacylglyceride concentration and apolipoprotein E polymorphism on postprandial lipemia. Arterioscler Thromb 1991, 11: 1737\u20131744.","journal-title":"Arterioscler Thromb"},{"key":"25_CR121","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1172\/JCI110330","volume":"68","author":"WJ Schneider","year":"1981","unstructured":"Schneider WJ, Kovanen PT, Brown MS, et al.: Familial dysbetalipoproteinemia: abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest 1981, 68: 1075\u20131085.","journal-title":"J Clin Invest"},{"key":"25_CR122","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1399-0004.1984.tb01995.x","volume":"25","author":"AM Cumming","year":"1984","unstructured":"Cumming AM, Robertson FW. Polymorphism at the apoprotein-E locus in relation to risk of coronary disease. Clin Genet 1984, 25: 310\u2013313.","journal-title":"Clin Genet"},{"key":"25_CR123","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/01.ATV.14.10.1617","volume":"14","author":"L Tiret","year":"1994","unstructured":"Tiret L, De Knijff P, Menzel HJ, et al.: ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations: the EARS Study: European Atherosclerosis Research Study. Arterioscler Thromb 1994, 14: 1617\u20131624.","journal-title":"Arterioscler Thromb"},{"key":"25_CR124","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0021-9150(95)05540-D","volume":"116","author":"RE Peacock","year":"1995","unstructured":"Peacock RE, Karpe F, Talmud PJ, et al.: Common variation in the gene for apolipoprotein B modulates postprandial lipoprotein metabolism: a hypothesis generating study. Atherosclerosis 1995, 116: 135\u2013145.","journal-title":"Atherosclerosis"},{"key":"25_CR125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0021-9150(96)05932-1","volume":"127","author":"CD Byrne","year":"1996","unstructured":"Byrne CD, Wareham NJ, Mistry PK, et al.: The association between free fatty acid concentrations and triglyceride-rich lipoproteins in the post-prandial state is altered by a common deletion polymorphism of the apo B signal peptide. Atherosclerosis 1996, 127: 35\u201342.","journal-title":"Atherosclerosis"},{"key":"25_CR126","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0021-9150(95)05589-O","volume":"118","author":"A Regis-Bailly","year":"1995","unstructured":"Regis-Bailly A, Fournier B, Steinmetz J, et al.: Apo B signal peptide insertion\/deletion polymorphism is involved in postprandial lipoparticles\u2019 responses. Atherosclerosis 1995, 118: 23\u201334.","journal-title":"Atherosclerosis"},{"key":"25_CR127","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1172\/JCI111711","volume":"75","author":"CS Wang","year":"1985","unstructured":"Wang CS, McConathy WJ, Kloer HU, et al.: Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest 1985, 75: 384\u2013390.","journal-title":"J Clin Invest"},{"key":"25_CR128","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI119456","volume":"99","author":"T Ebara","year":"1997","unstructured":"Ebara T, Ramakrishnan R, Steiner G, et al.: Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice: apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E. J Clin Invest 1997, 99: 2672\u20132681.","journal-title":"J Clin Invest"},{"key":"25_CR129","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1172\/JCI116066","volume":"90","author":"K Aalto-Setala","year":"1992","unstructured":"Aalto-Setala K, Fisher EA, Chen X, et al.: Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice: diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J Clin Invest 1992, 90: 1889\u20131900.","journal-title":"J Clin Invest"},{"key":"25_CR130","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(83)91440-X","volume":"1","author":"A Rees","year":"1983","unstructured":"Rees A, Shoulders CC, Stocks J, et al.: DNA polymorphism adjacent to human apoprotein A-1 gene: relation to hypertriglyceridaemia. Lancet 1983, 1: 444\u2013446.","journal-title":"Lancet"},{"key":"25_CR131","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1073\/pnas.90.10.4562","volume":"90","author":"M Dammerman","year":"1993","unstructured":"Dammerman M, Sandkuijl LA, Halaas JL, et al.: An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3\u2032 untranslated region polymorphisms. Proc Natl Acad Sci U S A 1993, 90: 4562\u20134566.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"25_CR132","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1161\/01.ATV.16.8.941","volume":"16","author":"AP Surguchov","year":"1996","unstructured":"Surguchov AP, Page GP, Smith L, et al.: Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia. Arterioscler Thromb Vasc Biol 1996, 16: 941\u2013947.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25_CR133","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1172\/JCI118324","volume":"96","author":"WW Li","year":"1995","unstructured":"Li WW, Dammerman MM, Smith JD, et al.: Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia [see comments]. J Clin Invest 1995, 96: 2601\u20132605.","journal-title":"J Clin Invest"},{"key":"25_CR134","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/01.CIR.99.14.1872","volume":"99","author":"DM Waterworth","year":"1999","unstructured":"Waterworth DM, Ribalta J, Nicaud V, et al.: ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests. Circulation 1999, 99: 1872\u20131877.","journal-title":"Circulation"},{"key":"25_CR135","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/clinchem\/45.3.331","volume":"45","author":"H Esterbauer","year":"1999","unstructured":"Esterbauer H, Hell E, Krempler F, et al.: Allele-specific differences in apolipoprotein C-III mRNA expression in human liver. Clin Chem 1999, 45: 331\u2013339.","journal-title":"Clin Chem"},{"key":"25_CR136","first-page":"585","volume":"58","author":"JI Rotter","year":"1996","unstructured":"Rotter JI, Bu X, Cantor RM, et al.: Multilocus genetic determinants of LDL particle size in coronary artery disease families. Am J Hum Genet 1996, 58: 585\u2013594.","journal-title":"Am J Hum Genet"},{"key":"25_CR137","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/01.ATV.18.10.1606","volume":"18","author":"JJ Agren","year":"1998","unstructured":"Agren JJ, Valve R, Vidgren H, et al.: Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene [published erratum appears in Arterioscler Thromb Vasc Biol 1999 Jan, 19(1):186]. Arterioscler Thromb Vasc Biol 1998, 18: 1606\u20131610.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25_CR138","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1074\/jbc.271.18.10892","volume":"271","author":"LJ Baier","year":"1996","unstructured":"Baier LJ, Bogardus C, Sacchettini JC. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 1996, 271: 10892\u201310896.","journal-title":"J Biol Chem"},{"key":"25_CR139","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1172\/JCI117778","volume":"95","author":"LJ Baier","year":"1995","unstructured":"Baier LJ, Sacchettini JC, Knowler WC, et al.: An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995, 95: 1281\u20131287.","journal-title":"J Clin Invest"},{"key":"25_CR140","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1432-2277.1999.tb00622.x","volume":"12","author":"B Foger","year":"1999","unstructured":"Foger B, Konigsrainer A, Ritsch A, et al.: Pancreas transplantation modulates reverse cholesterol transport. Transpl Int 1999, 12: 360\u2013364.","journal-title":"Transpl Int"},{"key":"25_CR141","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0026-0495(96)90159-6","volume":"45","author":"B Foger","year":"1996","unstructured":"Foger B, Konigsrainer A, Palos G, et al.: Effects of pancreas transplantation on distribution and composition of plasma lipoproteins. Metabolism 1996, 45: 856\u2013861.","journal-title":"Metabolism"},{"key":"25_CR142","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1172\/JCI105472","volume":"45","author":"JW Farquhar","year":"1966","unstructured":"Farquhar JW, Frank A, Gross RC, et al.: Glucose, insulin, and triglyceride responses to high and low carbohydrate diets in man. J Clin Invest 1966, 45: 1648\u20131656.","journal-title":"J Clin Invest"},{"key":"25_CR143","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1172\/JCI105666","volume":"46","author":"GM Reaven","year":"1967","unstructured":"Reaven GM, Lerner RL, Stern MP, et al.: Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 1967, 46: 1756\u20131767.","journal-title":"J Clin Invest"},{"key":"25_CR144","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1172\/JCI110865","volume":"71","author":"W Patsch","year":"1983","unstructured":"Patsch W, Franz S, Schonfeld G. Role of insulin in lipoprotein secretion by cultured rat hepatocytes. J Clin Invest 1983, 71: 1161\u20131174.","journal-title":"J Clin Invest"},{"key":"25_CR145","doi-asserted-by":"crossref","first-page":"9603","DOI":"10.1016\/S0021-9258(18)67556-8","volume":"261","author":"W Patsch","year":"1986","unstructured":"Patsch W, Gotto AMJ, Patsch JR. Effects of insulin on lipoprotein secretion in rat hepatocyte cultures: the role of the insulin receptor. J Biol Chem 1986, 261: 9603\u20139606.","journal-title":"J Biol Chem"},{"key":"25_CR146","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1172\/JCI117633","volume":"95","author":"GF Lewis","year":"1995","unstructured":"Lewis GF, Uffelman KD, Szeto LW, et al.: Interaction between free fatty acids and insulin in the acute control of very low-density lipoprotein production in humans. J Clin Invest 1995, 95: 158\u2013166.","journal-title":"J Clin Invest"},{"key":"25_CR147","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0022-2275(20)39865-5","volume":"36","author":"MC Lin","year":"1995","unstructured":"Lin MC, Gordon D, Wetterau JR: Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression. J Lipid Res 1995, 36: 1073\u20131081.","journal-title":"J Lipid Res"},{"key":"25_CR148","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1126\/science.1439810","volume":"258","author":"JR Wetterau","year":"1992","unstructured":"Wetterau JR, Aggerbeck LP, Bouma ME, et al.: Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 1992, 258: 999\u20131001.","journal-title":"Science"},{"key":"25_CR149","doi-asserted-by":"crossref","first-page":"30693","DOI":"10.1074\/jbc.272.49.30693","volume":"272","author":"TL Phung","year":"1997","unstructured":"Phung TL, Roncone A, Jensen KL, et al.: Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum. J Biol Chem 1997, 272: 30693\u201330702.","journal-title":"J Biol Chem"},{"key":"25_CR150","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0021-9258(17)31275-9","volume":"264","author":"KM Cianflone","year":"1989","unstructured":"Cianflone KM, Sniderman AD, Walsh MJ, et al.: Purification and characterization of acylation stimulating protein. J Biol Chem 1989, 264: 426\u2013430.","journal-title":"J Biol Chem"},{"key":"25_CR151","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1172\/JCI116733","volume":"92","author":"A Baldo","year":"1993","unstructured":"Baldo A, Sniderman AD, St-Luce S, et al.: The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 1993, 92: 1543\u20131547.","journal-title":"J Clin Invest"},{"key":"25_CR152","doi-asserted-by":"crossref","first-page":"20903","DOI":"10.1074\/jbc.273.33.20903","volume":"273","author":"T Scantlebury","year":"1998","unstructured":"Scantlebury T, Maslowska M, Cianflone K: Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes. J Biol Chem 1998, 273: 20903\u201320909.","journal-title":"J Biol Chem"},{"key":"25_CR153","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1172\/JCI114497","volume":"85","author":"KM Cianflone","year":"1990","unstructured":"Cianflone KM, Maslowska MH, Sniderman AD. Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein. J Clin Invest 1990, 85: 722\u2013730.","journal-title":"J Clin Invest"},{"key":"25_CR154","first-page":"E474","volume":"277","author":"I Murray","year":"1999","unstructured":"Murray I, Sniderman AD, Cianflone K: Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL\/6 mice. Am J Physiol 1999, 277: E474-E480.","journal-title":"Am J Physiol"},{"key":"25_CR155","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0022-2275(20)33413-1","volume":"40","author":"I Murray","year":"1999","unstructured":"Murray I, Sniderman AD, Cianflone K: Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance. J Lipid Res 1999, 40: 1671\u20131676.","journal-title":"J Lipid Res"},{"key":"25_CR156","doi-asserted-by":"crossref","first-page":"19429","DOI":"10.1074\/jbc.274.27.19429","volume":"274","author":"RA Wetsel","year":"1999","unstructured":"Wetsel RA, Kildsgaard J, Zsigmond E, et al.: Genetic deficiency of acylation stimulating protein (ASP(C3ades-Arg)) does not cause hyperapobetalipoproteinemia in mice. J Biol Chem 1999, 274: 19429\u201319433.","journal-title":"J Biol Chem"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-000-0025-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-000-0025-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-000-0025-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T01:23:47Z","timestamp":1628904227000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-000-0025-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":156,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["25"],"URL":"https:\/\/doi.org\/10.1007\/s11883-000-0025-0","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}